Botanical species · safety record

Mirabilis jalapa

The EFSA Compendium of Botanicals holds 9 constituent measurements for Mirabilis jalapa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Mirabilis jalapa L.

9Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Betalains	Flower	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Betalains	Flower	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Calcium oxalate	Leaves	Fresh	—	Microscopic detection	No resolvable identifier
Chrysophanol	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Trigonelline	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Trigonelline	Live plants	Solvent extraction	≥ 0.03 Millimol/100 Gramm	Unspecified	No resolvable identifier
Trigonelline	Live plants	Solvent extraction	≤ 1.3 Millimol/100 Gramm	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gandia-Herrero, F., Garcia-Carmona, F., Escribano, J. Fluorescent pigments: New perspectives in betalain research and applications. FOOD RESEARCH INTERNATIONAL, 2005, vol. 38, no. 8-9, p. 879-884. DOI
Song, Fenyun., Zhang, Dezhi., Zhong, Yunxiang., Wang, Wei., Zeng, Shaohui. Content determination of trigonelline in root of Mirabilis jalapa by reversed phase HPLC. Zhongyao xinyao yu linchuang yaoli, 2005, p. 189-191.
Nath, L.R., Manjunath, K.P., Savadi, R.V., Akki, K.S. Pharmacognostical and phytochemical studies of Mirabilis jalapa Linn. leaves. Pharmacognosy journal, 2009, vol. 1, no. 2, p. 111-115.
Piattelli, M., Minale, L., Nicolaus, R. A. Pigments of centrospermae. V. Betaxanthins from Mirabilis jalapa. Phytochemistry (Elsevier), 1965, p. 817-823.
Kuang, Jiale., Zhang, Dezhi. Chemical constituents of the root of Mirabilis jalapa. Guangdong yaoxueyuan xuebao, 2007, p. 1-2.
Ashihara, Hiroshi., Watanabe, Shin. Accumulation and Function of Trigonelline in Non-leguminous Plants. Natural product communications, 2014, vol. 9, no. 6, p. 795-798.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature